MARSHALL WACE, LLP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,172,741
+837.9%
89,093
+769.5%
0.01%
+900.0%
Q2 2023$551,542
+24.0%
10,246
-8.5%
0.00%0.0%
Q1 2023$444,824
-78.4%
11,199
-74.9%
0.00%
-75.0%
Q4 2021$2,055,000
+28.9%
44,600
+97.3%
0.00%
-50.0%
Q1 2019$1,594,000
+51.8%
22,606
+21.7%
0.01%
+100.0%
Q3 2018$1,050,00018,5780.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders